Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03361306
Title LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple M
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Saad Z. Usmani, MD
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
*Shaded cells indicate that there was no data available from for the field